SM
RGEN icon

Sciencast Management’s Repligen RGEN Stock Holding History

Sciencast Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,803
Closed -$255K – 433
2023
Q2 		$255K Buy
+1,803
New +$289K 0.21% 189
2022
Q1 		– Sell
-4,328
Closed -$1.01M – 726
2021
Q4 		$1.01M Buy
+4,328
New +$1.17M 0.18% 176
2021
Q2 		– Sell
-4,089
Closed -$841K – 664
2021
Q1 		$841K Buy
+4,089
New +$838K 0.17% 185
2020
Q4 		– Sell
-4,029
Closed -$702K – 591
2020
Q3 		$702K Buy
+4,029
New +$576K 0.27% 125

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sciencast Management's RGEN Position: Q3 2023 in Review

Sciencast Management sold out of Repligen (RGEN) in Q3 2023, closing a stake of 1,803 shares — an estimated $255K sold.

Sciencast Management first reported a position in RGEN in Q3 2020 and held it in 4 quarters. The position peaked at $1.01M in Q4 2021. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Sciencast Management reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Sciencast Management sold 1,803 Repligen shares in Q3 2023, an estimated $255K.
  • Sciencast Management first reported a position in Repligen in Q3 2020 and held it in 4 quarters.
  • Sciencast Management's Repligen position peaked at $1.01M in Q4 2021.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Sciencast Management's 13F filing for Q3 2023, filed 14 Nov 2023.